You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

634 Results
Regimen
Cancer Type:
Hematologic, 
Lymphoma - T-cell
Intent: Palliative
Funding:
New Drug Funding Program
    Mogamulizumab - Relapsed or Refractory Mycosis Fungoides or Sezary Syndrome
May 2024
Intro Text: Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam tempus urna nibh, et tempor nulla rhoncus vel. Maecenas sodales feugiat ex...
Drug
Other Name(s): Poteligeo®
May 2024

Pages